Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
Posted on:
Type
Research/project funding
Funding Opportunity PAR-23-119 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.